Keros Therapeutics, Inc. - common stock (KROS)
11.33
-0.38 (-3.25%)
Keros Therapeutics Inc is a biotechnology company focused on developing innovative therapies to treat rare hematological and muscle disorders
The company is dedicated to advancing its proprietary drug candidates that target the transforming growth factor beta (TGF-β) superfamily, which plays a critical role in various cellular processes, including muscle and blood formation. By leveraging their expertise in molecular biology and drug development, Keros Therapeutics aims to provide new treatment options for patients with unmet medical needs while fostering advancements in the understanding of these complex diseases.
Frequently Asked Questions
Is Keros Therapeutics, Inc. - common stock publicly traded?
Yes, Keros Therapeutics, Inc. - common stock is publicly traded.
What exchange does Keros Therapeutics, Inc. - common stock trade on?
Keros Therapeutics, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Keros Therapeutics, Inc. - common stock?
The ticker symbol for Keros Therapeutics, Inc. - common stock is KROS on the Nasdaq Stock Market
What is the current price of Keros Therapeutics, Inc. - common stock?
The current price of Keros Therapeutics, Inc. - common stock is 11.33
When was Keros Therapeutics, Inc. - common stock last traded?
The last trade of Keros Therapeutics, Inc. - common stock was at 1:30 pm EST on January 31st, 2025
What is the market capitalization of Keros Therapeutics, Inc. - common stock?
The market capitalization of Keros Therapeutics, Inc. - common stock is 264.42M
How many shares of Keros Therapeutics, Inc. - common stock are outstanding?
Keros Therapeutics, Inc. - common stock has 23.34M shares outstanding.